ISHLT 2021

41st Annual Meeting & Scientific Sessions

April 21, 2021 – April 23, 2021



Going to the 41st Annual Meeting & Scientific? Be sure to mark your calendars for our ISHLT 2021 Industry Symposium on Monday, April 26th!

Visit ISHLT to register for this event.  ISHLT Registration ❯



APR 26
10:45 am ET
1 hour

Innovations in Rejection Surveillance after Heart Transplantation

For post-transplant management in heart patients, the endomyocardial biopsy is considered the gold standard to detect acute rejection. However, research has found that in biopsy assessments for rejection, concordance among expert pathologists is less than 67%. This presentation will explore case studies and the clinical use of novel technologies, including molecular diagnostic testing of intragraft mRNA transcripts and donor-derived cell-free DNA, for more accurate diagnosis of cellular and antibody-mediated rejection, acute rejection, and cardiac allograft vasculopathy (CAV).

Dr. Christopher Lawrence, Director, Medical Affairs | Thermo Fisher Scientific

Jon A. Kobashigawa MD | Director, Heart Transplant Program
Cedars-Sinai Medical Center, Los Angeles, California

Follow us:  
Facebook LinkedIn Twitter  

(•▿•)> ⇣ Scroll down to see more Tweets.